Table 1.

Demographics, physical function and cognitive function, all subjects at Baseline

Variables Group	Aerobic Exercise		Control Condition
	N	Mean/Count	Std Dev/%	N	Mean/Count	Std Dev/%	T-test/Chi Sq	p-value
Age	21	52.52	6.66	17	53.18	10.27	–0.24	0.814
BMI	21	31.11	6.87	17	29.31	4.00	0.96	0.344
Sex*
Male	21	16.00	76.20	17	15.00	88.23		0.427
Race*
African American	21	19.00	90.50	17	17.00	100.00		0.492
Medication*
Atypical Antipsychotics	21	14.00	66.67	17	13.00	76.47		0.721
Typical Antipsychotics	21	1.00	4.76	17	2.00	11.76		0.577
Both (Atypical and Typical)	21	2.00	9.52	17	1.00	5.88		1.000
No Antipsychotics	21	4.00	19.05	17	1.00	5.88		0.355
Antidepressants	21	6.00	28.57	17	4.00	23.53		1.000
PANSS
Negative Symptoms	21	18.71	6.50	17	17.00	4.76	0.91	0.371
Positive Symptoms	21	15.29	3.80	17	14.53	2.85	0.68	0.501
Grand Total	21	62.38	12.79	17	59.94	8.99	0.66	0.511
SLOF
Composite	21	176.00	28.30	17	186.00	14.80	–1.31	0.198
UPSA
Composite	21	60.70	15.10	17	61.40	9.86	–0.17	0.862
Exercise
Time 400 m (s)	21	359.00	58.00	16	345.00	57.20	0.71	0.483
VO2 max (mL/kg/min)	17	28.00	10.30	12	30.50	6.69	–0.73	0.473
MATRICS
Composite	21	26.10	12.48	17	25.47	9.87	0.17	0.868
Domains
Attention/Vigilance	21	33.67	11.35	17	34.88	11.86	–0.32	0.750
Reasoning and Problem Solving	21	43.81	8.27	17	38.76	4.25	2.28	0.029
Social Cognition	21	30.81	11.04	17	34.41	14.20	–0.88	0.385
Speed of Processing	21	32.38	13.30	17	34.94	15.80	–0.54	0.591
Visual Learning	21	35.62	12.48	17	30.24	9.72	1.46	0.154
Verbal Learning	21	36.71	5.41	17	36.29	11.16	0.14	0.888
Working Memory	21	34.57	14.67	17	34.94	9.63	–0.09	0.929
BDNF Concentration (pg/mL)	21	208.89	70.07	17	215.91	123.14	–0.22	0.826

*Denotes use of Fisher Exact test given small sample size.